Helios Technologies Provides Update on Status from Hurricane Milton

SARASOTA, Fla.--(BUSINESS WIRE)-- Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology, today provided a preliminary update on its status from Hurricane Milton.

"Our immediate concern is for the safety and well-being of our colleagues, their families, and the residents of the communities throughout the region affected by this devastating storm," said Sean Bagan, Interim President, Chief Executive Officer, and Chief Financial Officer of Helios. “Sarasota, which was directly hit by the hurricane, is home to our worldwide corporate headquarters and our operating company Sun Hydraulics, a material part of our Hydraulics segment. The extent of the damage and disruption are being assessed at our Florida facilities and we are working to fully determine the physical impact of the storm on our manufacturing operations. We have engaged with our insurance partners to minimize the financial impact from any physical losses we have sustained. Our objective is to have our affected locations up and running again as quickly as possible.”

Once it has completed its assessment and as more information is available, the Company plans to provide further updates and its estimates of the effects of Hurricane Milton on its financial results and operations.

About Helios Technologies

Helios Technologies is a global leader in highly engineered motion control and electronic controls technology for diverse end markets, including construction, material handling, agriculture, energy, recreational vehicles, marine and health and wellness. Helios sells its products to customers in over 90 countries around the world. Its strategy for growth is to be the leading provider in niche markets, with premier products and solutions through innovative product development and acquisition. The Company has paid a cash dividend to its shareholders every quarter since becoming a public company in 1997. For more information please visit: www.heliostechnologies.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241010345129/en/

Investor and Media contacts:

Tania Almond
Vice President, Investor Relations and Corporate Communication
(941) 362-1333
[email protected]

Deborah Pawlowski
Kei Advisors LLC
(716) 843-3908
[email protected]

Source: Helios Technologies, Inc.

You May Also Be Interested In

• H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
• Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal